对SIRT6脱酶酶活性的结构和酶可塑性
Zhipeng A Wang1, Jonathan Markert2, Samuel D Whedon3
1Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, United States; Desai Sethi Urology Institute & Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, United States.
The Journal of biological chemistry
|March 27, 2025
概括
赛尔图因6 (SIRT6) 是基因组稳定性和表观遗传控制中的关键酶. 这项研究揭示了SIRT6.
科学领域:
- 生物化学 生物化学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 结构生物学 结构生物学
背景情况:
- 赛尔图因6 (SIRT6) 是一种依赖NAD的脱乙酶,对于维持基因组稳定性和将新陈代谢与表观遗传学联系起来至关重要.
- SIRT6失调与衰老和癌症有关,这突显了其药理学意义.
- 了解SIRT6的基质特异性对于开发向疗法至关重要.
研究的目的:
- 阐明SIRT6基质识别和催化活性背后的分子机制.
- 调查SIRT6对各种核细胞基质和翻译后修改的适应性.
- 探索SIRT6在基因素脱甲基化过程中的结构灵活性的结构基础.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于可视化SIRT6核体复合体.
- 酶学和生物化学测试以评估SIRT6活性和基质偏好.
- 对酶突变和小分子调制剂的分析,以探测基质选择性.
主要成果:
- 可视化了一个SIRT6脱糖H3K27的被困复合体,揭示了基因组标记去除的构造变化.
- 证明了SIRT6在适应各种与代谢相关的修饰过程中的可塑性,包括 lysine 乳糖化和 β-hydroxybutyrylation.
- 鉴定了影响SIRT6基质选择性的关键因素,如酶突变和近接质素修饰.
结论:
- 在识别和修改多种核细胞基质方面,SIRT6表现出了显著的多功能性和适应性.
- 结构和生化洞察力为SIRT6的分子识别提供了机械的理解.
- 这些发现为针对衰老和癌症治疗的向药物开发铺平了道路.
相关概念视频
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
Protein Modifications in the RER
5.1K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.1K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K


